Abstract
The data on treatment of 50 patients with endometrial stromal sarcoma (Ess) are discussed. Mean age-46.5 years. The group included 28 patients with stage I tumor, 7-stage II, 8-stage III and 7-stage IV. The end results of surgical, combined and complex treatment were followed up in 45 cases. Surgery was given to 24 and combined and complex therapy-to 21 patients. Five- and ten-year survival was 55.6 and 26.7, respectively, whatever mode of therapy and stage.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Combined Modality Therapy
-
Evaluation Studies as Topic
-
Female
-
Humans
-
Hysterectomy
-
Middle Aged
-
Neoplasm Metastasis
-
Radiotherapy Dosage
-
Sarcoma, Endometrial Stromal / mortality
-
Sarcoma, Endometrial Stromal / radiotherapy
-
Sarcoma, Endometrial Stromal / surgery
-
Sarcoma, Endometrial Stromal / therapy*
-
Time Factors
-
Uterine Neoplasms / mortality
-
Uterine Neoplasms / radiotherapy
-
Uterine Neoplasms / surgery
-
Uterine Neoplasms / therapy*